Joshua J Joseph1, Justin B Echouffo-Tcheugui2,3, Mercedes R Carnethon4, Alain G Bertoni5, Christina M Shay6, Haitham M Ahmed7, Roger S Blumenthal7, Mary Cushman8, Sherita H Golden9. 1. Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, 1830 E. Monument St, Suite 333, Baltimore, MD, 21287, USA. 2. Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 3. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 4. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 5. Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC, USA. 6. Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. 7. Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 8. Department of Medicine, University of Vermont College of Medicine, Burlington, VT, USA. 9. Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, 1830 E. Monument St, Suite 333, Baltimore, MD, 21287, USA. sahill@jhmi.edu.
Abstract
AIMS/HYPOTHESIS: Levels of ideal cardiovascular health (ICH) and incident type 2 diabetes mellitus have not been examined in a multiethnic population. We assessed the total and race/ethnicity-specific incidence of diabetes based on American Heart Association (AHA) ICH components. METHODS: Incident diabetes was assessed among 5341 participants in the Multi-Ethnic Study of Atherosclerosis without prevalent diabetes between 2002 and 2012. ICH components (total cholesterol, BP, dietary intake, tobacco use, physical activity and BMI) were assessed at baseline and participants were categorised as having ideal, intermediate or poor cardiovascular health, as defined by the AHA 2020 impact goals. We developed a scoring system based on the number of ICH components (0-1 'poor', 2-3 'intermediate', and ≥4 'ideal'). HRs were calculated using Cox models. RESULTS: During a median follow-up of 11.1 years, we identified 587 cases of incident diabetes. After multivariable adjustment, participants with 2-3 and ≥4 ICH components vs 0-1 components had a 34% lower (HR 0.66; 95% CI 0.54, 0.80) and a 75% lower (HR 0.25; 95% CI 0.18, 0.35) diabetes incidence, respectively. There were significant differences by race/ethnicity: African-American and Hispanic-American participants with ≥4 ICH components had diabetes incidence rates per 1000 person-years of 5.6 (95% CI 3.1, 10.1) and 10.5 (95% CI 6.7, 16.4), respectively, compared with 2.2 (95% CI 1.3, 3.7) among non-Hispanic white Americans. CONCLUSIONS/ INTERPRETATION: Meeting an increasing number of AHA 2020 impact goals for dietary intake, physical activity, smoking, BP, cholesterol and BMI was associated with a dose-dependent lower risk of diabetes with significant variation by race/ethnicity.
AIMS/HYPOTHESIS: Levels of ideal cardiovascular health (ICH) and incident type 2 diabetes mellitus have not been examined in a multiethnic population. We assessed the total and race/ethnicity-specific incidence of diabetes based on American Heart Association (AHA) ICH components. METHODS: Incident diabetes was assessed among 5341 participants in the Multi-Ethnic Study of Atherosclerosis without prevalent diabetes between 2002 and 2012. ICH components (total cholesterol, BP, dietary intake, tobacco use, physical activity and BMI) were assessed at baseline and participants were categorised as having ideal, intermediate or poor cardiovascular health, as defined by the AHA 2020 impact goals. We developed a scoring system based on the number of ICH components (0-1 'poor', 2-3 'intermediate', and ≥4 'ideal'). HRs were calculated using Cox models. RESULTS: During a median follow-up of 11.1 years, we identified 587 cases of incident diabetes. After multivariable adjustment, participants with 2-3 and ≥4 ICH components vs 0-1 components had a 34% lower (HR 0.66; 95% CI 0.54, 0.80) and a 75% lower (HR 0.25; 95% CI 0.18, 0.35) diabetes incidence, respectively. There were significant differences by race/ethnicity: African-American and Hispanic-American participants with ≥4 ICH components had diabetes incidence rates per 1000 person-years of 5.6 (95% CI 3.1, 10.1) and 10.5 (95% CI 6.7, 16.4), respectively, compared with 2.2 (95% CI 1.3, 3.7) among non-Hispanic white Americans. CONCLUSIONS/ INTERPRETATION: Meeting an increasing number of AHA 2020 impact goals for dietary intake, physical activity, smoking, BP, cholesterol and BMI was associated with a dose-dependent lower risk of diabetes with significant variation by race/ethnicity.
Authors: Linda M Delahanty; Qing Pan; Kathleen A Jablonski; Vanita R Aroda; Karol E Watson; George A Bray; Steven E Kahn; Jose C Florez; Leigh Perreault; Paul W Franks Journal: Diabetes Care Date: 2014-07-14 Impact factor: 19.112
Authors: Ivonne Sluijs; Yvonne T van der Schouw; Daphne L van der A; Annemieke M Spijkerman; Frank B Hu; Diederick E Grobbee; Joline W Beulens Journal: Am J Clin Nutr Date: 2010-08-04 Impact factor: 7.045
Authors: M A Martínez-González; C de la Fuente-Arrillaga; J M Nunez-Cordoba; F J Basterra-Gortari; J J Beunza; Z Vazquez; S Benito; A Tortosa; M Bes-Rastrollo Journal: BMJ Date: 2008-05-29
Authors: Koert N J Burger; Joline W J Beulens; Jolanda M A Boer; Annemieke M W Spijkerman; Daphne L van der A Journal: PLoS One Date: 2011-10-05 Impact factor: 3.240
Authors: Kathryn S Taylor; Carl J Heneghan; Andrew J Farmer; Alice M Fuller; Amanda I Adler; Jeffrey K Aronson; Richard J Stevens Journal: Diabetes Care Date: 2013-02-22 Impact factor: 19.112
Authors: Amanda M Fretts; Barbara V Howard; Barbara McKnight; Glen E Duncan; Shirley A A Beresford; Mihriye Mete; Ying Zhang; David S Siscovick Journal: Diabetes Care Date: 2014-05-07 Impact factor: 19.112
Authors: Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph Journal: Psychoneuroendocrinology Date: 2018-12-27 Impact factor: 4.905
Authors: Joshua J Joseph; Justin B Echouffo-Tcheugui; Sameera A Talegawkar; Valery S Effoe; Victoria Okhomina; Mercedes R Carnethon; Willa A Hsueh; Sherita H Golden Journal: Am J Prev Med Date: 2017-08-14 Impact factor: 5.043
Authors: William R Boyer; James R Churilla; Samantha F Ehrlich; Scott E Crouter; Lyndsey M Hornbuckle; Eugene C Fitzhugh Journal: J Diabetes Date: 2017-07-04 Impact factor: 4.006
Authors: Jeong Hwan Kim; Shabatun J Islam; Matthew L Topel; Yi-An Ko; Mahasin S Mujahid; Viola Vaccarino; Chang Liu; Mario Sims; Mohamed Mubasher; Charles D Searles; Sandra B Dunbar; Priscilla Pemu; Herman A Taylor; Arshed A Quyyumi; Peter Baltrus; Tené T Lewis Journal: Circ Cardiovasc Qual Outcomes Date: 2020-10-07
Authors: Shabatun J Islam; Jeong Hwan Kim; Peter Baltrus; Matthew L Topel; Chang Liu; Yi-An Ko; Mahasin S Mujahid; Viola Vaccarino; Mario Sims; Mohamed Mubasher; Ahsan Khan; Kiran Ejaz; Charles Searles; Sandra Dunbar; Priscilla Pemu; Herman A Taylor; Arshed A Quyyumi; Tené T Lewis Journal: Ann Epidemiol Date: 2020-12-05 Impact factor: 3.797
Authors: Guo-Chong Chen; Qibin Qi; Simin Hua; Jee-Young Moon; Nicole L Spartano; Ramachandran S Vasan; Daniela Sotres-Alvarez; Sheila F Castaneda; Kelly R Evenson; Krista M Perreira; Linda C Gallo; Amber Pirzada; Keith M Diaz; Martha L Daviglus; Marc D Gellman; Robert C Kaplan; Xiaonan Xue; Yasmin Mossavar-Rahmani Journal: Am J Clin Nutr Date: 2020-11-11 Impact factor: 7.045